Overview

Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis

Status:
Unknown status

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the Efficacy, Tolerability & Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, used for 7 consecutive days in patients with Mixed-Type Vaginosis compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream.

Phase:

Phase 3

Details

Lead Sponsor:

Zodiac Produtos Farmaceuticos S.A.

Treatments:

Amphotericin B
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Ketoconazole
Liposomal amphotericin B
Tetracycline